Spots Global Cancer Trial Database for pancreatic diseases
Every month we try and update this database with for pancreatic diseases cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic Ca | NCT01555489 | Stage IV Pancre... | Ascorbic Acid | 18 Years - | Thomas Jefferson University | |
| A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma | NCT02993731 | Carcinoma, Panc... | Napabucasin Nab-paclitaxel Gemcitabine | 18 Years - | Sumitomo Pharma America, Inc. | |
| 89Zr-MMOT PET Imaging in Pancreatic and Ovarian Cancer Patients | NCT01832116 | Ovarian Neoplas... Ovarian Disease... Adnexal Disease... Pancreatic Neop... Digestive Syste... Digestive Syste... Pancreatic Dise... | 89Zr-MMOT0530A | 18 Years - | University Medical Center Groningen | |
| Improvement of Care of Patients Undergoing Pancreaticoduodenectomy | NCT04668781 | Pancreatic Dise... Pancreas Cancer | Analgesia via e... Analgesia via w... | 18 Years - 90 Years | Helsinki University Central Hospital | |
| PAncreatic Disease Cohort of TOuLouse | NCT05824403 | Pancreatic Dise... | 18 Years - | University Hospital, Toulouse | ||
| Protocol to Permit the Acquisition of Circulating Tumor Material in Pancreatic Diseases | NCT02471170 | Pancreatic Dise... | 18 Years - | Abramson Cancer Center at Penn Medicine | ||
| Protocol to Permit the Acquisition of Circulating Tumor Material in Pancreatic Diseases | NCT02471170 | Pancreatic Dise... | 18 Years - | Abramson Cancer Center at Penn Medicine | ||
| Hedgehog Inhibitors for Metastatic Adenocarcinoma of the Pancreas | NCT01088815 | Metastatic Panc... | Gemcitabine, na... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer | NCT03535727 | Adenocarcinoma Pancreatic Neop... Neoplasm, Gland... Neoplasms Neoplasms Pancr... Digestive Syste... Endocrine Gland... Digestive Syste... Pancreatic Dise... Endocrine Syste... | Nab-paclitaxel Gemcitabine Capecitabine Cisplatin Irinotecan Nab-paclitaxel Gemcitabine Capecitabine Cisplatin Irinotecan | 18 Years - 76 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| PAncreatic Disease Cohort of TOuLouse | NCT05824403 | Pancreatic Dise... | 18 Years - | University Hospital, Toulouse | ||
| Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma | NCT03717298 | Adenocarcinoma ... Pancreatic Canc... Advanced Cancer Digestive Syste... Pancreatic Neop... Endocrine Gland... Digestive Syste... Endocrine Syste... Pancreatic Dise... | Ocoxin-Viusid® | 18 Years - | Catalysis SL | |
| Retrospective Study on Microbial Diversity in Paraffin Tissue of Pancreatic Diseases | NCT05193162 | Pancreatic Canc... Pancreatic Dise... Microbial Colon... | No any interven... | 5 Years - 85 Years | Ruijin Hospital | |
| Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic Ca | NCT01555489 | Stage IV Pancre... | Ascorbic Acid | 18 Years - | Thomas Jefferson University | |
| RCT: Difference in Diagnostic Yield Between EUSFNA Needles With and Without a Side Port in Pancreatic Masses | NCT02092519 | Pancreatic Neop... Pancreatic Dise... | Needle with sid... Needle without ... | 21 Years - | Changi General Hospital | |
| Improving Pancreatic Cancer Care by the Use of Computational Science and Technology | NCT06055010 | Pancreatic Canc... Pancreatic Cyst Pancreatic Aden... Pancreatic Dise... Pancreas Adenoc... Pancreas Cyst | No intervention... | - | UMC Utrecht | |
| Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma | NCT03717298 | Adenocarcinoma ... Pancreatic Canc... Advanced Cancer Digestive Syste... Pancreatic Neop... Endocrine Gland... Digestive Syste... Endocrine Syste... Pancreatic Dise... | Ocoxin-Viusid® | 18 Years - | Catalysis SL | |
| Pancreatic Cancer Screening Through the Detection of Elastase-1 Combined With Other Examinations | NCT06041009 | Pancreatic Duct... Pancreatic Dise... Pancreatic Elas... Pancreatic Neur... Pancreatitis Pancreatic Neop... | Pancreatic elas... | 18 Years - | Qilu Hospital of Shandong University | |
| Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy | NCT00526331 | Esophageal Dise... Gastrointestina... Disorder of the... Gynecologic Dis... Kidney Diseases Liver Diseases Pancreatic Dise... Prostate Cancer Spinal Disease | Vigileo Monitor FloTrac Sensor | 18 Years - | M.D. Anderson Cancer Center | |
| Improvement of Care of Patients Undergoing Pancreaticoduodenectomy | NCT04668781 | Pancreatic Dise... Pancreas Cancer | Analgesia via e... Analgesia via w... | 18 Years - 90 Years | Helsinki University Central Hospital | |
| Screening of Postoperative Pulmonary Complications by Electrical Impedance Tomography | NCT02337673 | Pulmonary Disea... Postoperative R... Malignant Neopl... Liver Diseases Pancreatic Dise... | 18 Years - | Johannes Gutenberg University Mainz | ||
| Primary Needle Knife Fistulotomy Versus Conventional Cannulation Method | NCT02916199 | Common Bile Duc... Malignant Hepat... Biliary Strictu... Pancreatic Dise... Sphincter of Od... | cannulation of ... | 19 Years - 90 Years | Gangnam Severance Hospital | |
| Trial of NanoPac® in Subjects With Locally Advanced Pancreatic Adenocarcinoma | NCT03077685 | Locally Advance... | NanoPac® | 18 Years - | NanOlogy, LLC | |
| UCSF PANC Cyst Registry | NCT04291651 | Pancreatic Cyst Pancreatic Neop... Pancreatic Canc... Pancreatic Dise... Pancreatic Intr... Intraductal Pap... Pancreatic Duct... Mucinous Cyst | Survey | 18 Years - | University of California, San Francisco | |
| A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic Cancer | NCT02231723 | Metastatic Panc... | BBI608 Nab-paclitaxel Gemcitabine Oxaliplatin Leucovorin Irinotecan Fluorouracil MM-398 | 18 Years - | Sumitomo Pharma America, Inc. | |
| Analysis of Biliary Microbiota in Hepatobiliopancreatic Diseases Compared to Healthy People [MICROBILIO] | NCT04391426 | Pancreatic Dise... Microbiota Early Detection... Dysbiosis Biliary Tract D... | 18 Years - | University of Sao Paulo | ||
| Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy? | NCT03269994 | Pancreatic Canc... Pancreas Cancer Pancreatic Dise... | Cefoxitin Piperacillin-ta... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Intracystic Injection of NanoPac® in Subjects With Mucinous Cystic Pancreatic Neoplasms | NCT03188991 | Pancreatic Muci... | NanoPac® | 18 Years - | NanOlogy, LLC | |
| Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study) | NCT01964430 | Pancreatic Neop... Digestive Syste... Neoplasms by Si... Neoplasms Endocrine Gland... Pancreatic Dise... Digestive Syste... Endocrine Syste... Gemcitabine Antimetabolites... | nab-Paclitaxel Gemcitabine | 18 Years - | Celgene | |
| Gemcitabine + Nab-paclitaxel With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma | NCT01431794 | Pancreatic Duct... | LDE225-600mg Gemcitabine nab-paclitaxel LDE225-400mg LDE225-800mg | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| POstopeRative Standardization of Care: THe Implementation of Best Practice After Pancreatic Resection | NCT03400280 | Pancreatic Dise... Pancreatic Neop... Pancreatic Canc... Pancreatitis | Best practice a... | - | St. Antonius Hospital | |
| POstopeRative Standardization of Care: THe Implementation of Best Practice After Pancreatic Resection | NCT03400280 | Pancreatic Dise... Pancreatic Neop... Pancreatic Canc... Pancreatitis | Best practice a... | - | St. Antonius Hospital | |
| Predictive Biomarkers of Response to Sunitinib in the Treatment of Poorly-differentiated NEURO-Endocrine Tumors | NCT01215578 | Neuroendocrine ... Pancreatic Neop... Advanced Diseas... Sunitinib | Sutent | 18 Years - | Assistance Publique - Hôpitaux de Paris |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
